Pacira BioSciences, Inc. (PCRX)

NASDAQ: PCRX · Real-Time Price · USD

22.24

+0.24 (1.09%)

At close: Mar 9, 2026, 4:00 PM EDT

23.00

+0.76 (3.42%)

After-hours: Mar 9, 2026, 4:24 PM EDT

Pacira BioSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	158.55	276.77	153.3	104.14	585.58
Cash & Short-Term Investments	158.55	276.77	153.3	104.14	585.58
Cash Growth	-42.72%	80.55%	47.21%	-82.22%	485.83%
Total Current Assets	158.55	276.77	153.3	104.14	585.58
Total Assets	158.55	276.77	153.3	104.14	585.58
Long-Term Debt	372.19	-	-	-	-
Total Long-Term Liabilities	372.19	-	-	-	-
Total Liabilities	372.19	-	-	-	-
Total Liabilities & Equity	372.19	-	-	-	-
Total Debt	372.19	0	0	0	0
Net Cash (Debt)	-213.64	276.77	153.3	104.14	585.58
Net Cash Growth	-	80.55%	47.21%	-82.22%	485.83%
Net Cash Per Share	-4.74	5.99	2.95	2.24	12.83

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q